Literature DB >> 12930104

Practice patterns of lymph-node mapping and sentinel-node biopsy for breast cancer in British Columbia.

Boon Chua1, Ivo A Olivotto, James C Donald, Allen H Hayashi, Noelle Davis, Conrad H Rusnak.   

Abstract

INTRODUCTION: Because there is no standardized technique for mapping of lymph nodes and no optimal technique for evaluating the sentinel node, we decided to evaluate practice patterns for sentinel-node biopsy (SNB) for breast cancer in British Columbia 5 years after its introduction in 1996.
METHODS: We carried out mail and telephone surveys of general surgeons performing at least 1 SNB (n = 28) or not performing SNB (n = 50), and carried out telephone surveys or on-site visits with pathologists (n = 7) and nuclear medicine physicians (n = 5) from institutions supporting SNB in the province. We collected data on training, perceived indications and techniques for the surgical, imaging and pathologic assessments of SNB to obtain data on practice patterns in 2001 and the degree of consistency among surgeons and institutions involved in performing SNB and reasons for not adopting the SNB technique.
RESULTS: By 2001, SNB was incorporated into the practice of 19% of surgeons (28 of 150) performing breast cancer surgery in British Columbia. The survey response rate among SNB surgeons was 89% (25 of 28). Twelve (48%) of the 25 surgeons implemented SNB in the context of a validation study. Ten (40%) of the 25 had no data management support to monitor their results. Surgical training included intraoperative mentoring alone (48%), formal training courses alone (20%), both (24%) and self-teaching (8%). One-third of the surgeons had performed fewer than 10 procedures. Five surgeons had abandoned routine axillary dissection. There was considerable variation regarding the indications for SNB, definition of a sentinel node and surgical techniques. All nuclear medicine departments had a written lymphatic mapping protocol, but each used a different volume and activity of radiotracer. Immunohistochemical evaluation of the sentinel nodes was performed at just 3 pathology laboratories. The survey response rate from surgeons not practising SNB was 54% (27 of 50). Among 24 responders in active practice, 7 (29%) planned to perform SNB; 79% had not decided on the SNB indications. Lack of operating room time was a major limiting factor.
CONCLUSIONS: There was considerable variation in the surgical, nuclear medicine and pathology techniques for SNB in the absence of a planned approach for its implementation in British Columbia. Developing consensus around written guidelines for the indications and techniques of SNB may reduce this variation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930104      PMCID: PMC3211647     

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  26 in total

1.  Mapping a pathway for axillary staging: a personal perspective on the current status of sentinel lymph node dissection for breast cancer.

Authors:  A E Giuliano
Journal:  Arch Surg       Date:  1999-02

Review 2.  Comprehensive review of the management of internal mammary lymph node metastases in breast cancer.

Authors:  N Klauber-DeMore; J L Bevilacqua; K J Van Zee; P Borgen; H S Cody
Journal:  J Am Coll Surg       Date:  2001-11       Impact factor: 6.113

3.  The British Columbia Cancer Agency: a comprehensive and integrated system of cancer control.

Authors:  D R Carlow
Journal:  Hosp Q       Date:  2000

4.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.

Authors:  C L Carter; C Allen; D E Henson
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

5.  Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.

Authors:  C E Cox; S Pendas; J M Cox; E Joseph; A R Shons; T Yeatman; N N Ku; G H Lyman; C Berman; F Haddad; D S Reintgen
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

6.  Sentinel lymphadenectomy in breast cancer.

Authors:  A E Giuliano; R C Jones; M Brennan; R Statman
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

7.  Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy.

Authors:  J Cantin; H Scarth; M Levine; M Hugi
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

8.  Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure.

Authors:  E R Fisher; R Sass; B Fisher
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

9.  Internal mammary node status: a major prognosticator in axillary node-negative breast cancer.

Authors:  H S Cody; J A Urban
Journal:  Ann Surg Oncol       Date:  1995-01       Impact factor: 5.344

10.  The sentinel node in breast cancer--a multicenter validation study.

Authors:  D Krag; D Weaver; T Ashikaga; F Moffat; V S Klimberg; C Shriver; S Feldman; R Kusminsky; M Gadd; J Kuhn; S Harlow; P Beitsch
Journal:  N Engl J Med       Date:  1998-10-01       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.